in vivo fly RNAi
High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model.” PLoS One, 6, 8, Pp. e23841.Abstract
. 2011. “
FlyRNAi: the Drosophila RNAi screening center database.” Nucleic Acids Res, 34, Database issue, Pp. D489-94.Abstract
. 2006. “
Functional screening in Drosophila identifies Alzheimer's disease susceptibility genes and implicates Tau-mediated mechanisms.” Hum Mol Genet, 23, 4, Pp. 870-7.Abstract
. 2014. “
Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster.” Nat Methods, 5, 1, Pp. 49-51.Abstract
. 2008. “
RNAi screening in Drosophila cells and in vivo.” Methods, 68, 1, Pp. 82-8.Abstract
. 2014. “
Depleting gene activities in early Drosophila embryos with the "maternal-Gal4-shRNA" system.” Genetics, 193, 1, Pp. 51-61.Abstract
. 2013. “
In vivo RNAi: today and tomorrow.” Cold Spring Harb Perspect Biol, 2, 8, Pp. a003640.Abstract
. 2010. “
The Transgenic RNAi Project at Harvard Medical School: Resources and Validation.” Genetics, 201, 3, Pp. 843-52.Abstract
. 2015. “
The evolutionarily conserved protein CG9186 is associated with lipid droplets, required for their positioning and for fat storage.” J Cell Sci, 126, Pt 10, Pp. 2198-212.Abstract
. 2013. “
False negative rates in Drosophila cell-based RNAi screens: a case study.” BMC Genomics, 12, Pp. 50.Abstract
. 2011. “